Florent Ubelmann

@florubel

Enthusiast: Life sciences I Biotech I DNA repair I Oncology I Alzheimer's I Intracellular trafficking

Vrijeme pridruživanja: lipanj 2013.

Tweetovi

Blokirali ste korisnika/cu @florubel

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @florubel

  1. proslijedio/la je Tweet
    4. velj

    Today is not the day to ask for funds. Today is the day to take 5 min to remember those that you lost to this disease (💔x100), and phone (or even better, give a hug) to those that are fighting today.

    Poništi
  2. 3. velj
    Poništi
  3. proslijedio/la je Tweet
    21. sij

    Very excited to present our latest data on tumor targeting at this conference!

    Poništi
  4. proslijedio/la je Tweet
    17. sij
    Poništi
  5. proslijedio/la je Tweet
    17. sij

    Please help spreading! My lab is hiring a postdoc in clinical proteomics, aimed at discovering biomarkers of Alzheimer's disease. See

    Poništi
  6. proslijedio/la je Tweet
    16. sij

    1). END OF DAY 3 Created list of most interesting PRIVATE co's Looked for those w mix of buzz-y (🔥) assets + public HEALTHCARE SPECIALIST investors In Google Doc, ADDED AUDIO/SLIDES for 3 that were NOT WEBCAST: Avidity

    Prikaži ovu nit
    Poništi
  7. 16. sij

    Fantastic resource on ! If you're attending and have additional resource get in touch with

    Poništi
  8. proslijedio/la je Tweet
    2. sij

    In a recent SAB that spanned "Translation" to "Basic" research I restated my belief in a "Total Science" mindset echoing the great Johan Cruyff's "Total Football".

    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    1. sij

    CAU GCU CCU CCU UAC AAC GAA UGG UAC GAA GCU CGU!!!

    Poništi
  10. proslijedio/la je Tweet
    20. pro 2019.

    Here is the programme for our next intl. course on “genome instability and human disease” that will take place on April 2020 at . Check out the fantastic lineup of speakers and SAVE THE DATE!

    Poništi
  11. proslijedio/la je Tweet
    20. pro 2019.

    “Our vision is to address and in order to address cancer, you have to recognize that each patient is unique." Sean Marett shared how his company navigates the fundraising Maze: 💰

    Poništi
  12. proslijedio/la je Tweet
    19. pro 2019.

    Belmonte is a village in Portugal that managed to maintain itself, cryptically, Jewish throughout the Inquisition (and ever since)

    Poništi
  13. proslijedio/la je Tweet
    18. pro 2019.
    Poništi
  14. 17. pro 2019.
    Poništi
  15. proslijedio/la je Tweet
    15. pro 2019.

    DRUG DEVELOPMENT FOR JUST ONE PATIENT/ her name is Mila and she has a rare disease. A therapy was developed for her in less than one year (TRIAL N=1). An amazing team achievement & the future of rare diseases... so inspiring! what a privilege to work in life sciences today

    Poništi
  16. proslijedio/la je Tweet
    12. pro 2019.

    A Nature Medicine Editorial "The cost of getting personal" on personalized therapy

    Poništi
  17. proslijedio/la je Tweet
    9. pro 2019.

    I'll be an expert in origami by the end of this PhD

    Poništi
  18. 6. pro 2019.

    Great paper covering the development of the first siRNA drug! Thanks

    Poništi
  19. proslijedio/la je Tweet

    And how about aducanumab? Michael Ehlers teases plan to build the next signature genetic medicine company with $75M from Apple Tree Partners

    Poništi
  20. proslijedio/la je Tweet
    5. pro 2019.

    🚀La biotech anglaise Silence Therapeutics a progressé de 1088% en 6 mois. Elle est spécialisée dans le domaine scientifique le plus recherché en Biotech cette année : l'acide ribonucléique (ARN).

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·